During the past decade, Pacific Cancer Medical Center Inc conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 35 clinical trials were completed, i.e. on average, 79.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 15 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Cancer Medical Center Inc" #1 sponsor was "Novartis Pharmaceuticals" with 6 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 5 trials sponsored and "Incyte Corporation" with 5 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Cancer Medical Center Inc" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cephalon" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Cancer Medical Center Inc" are "Breast Cancer" (12 trials), "Lung Cancer" (5 trials), "Multiple Myeloma" (5 trials), "Neutropenia" (4 trials) and "Non-small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "Pacific Cancer Medical Center Inc" in a lesser frequency.

Most popular intervention types in "Pacific Cancer Medical Center Inc" are "Drug" (79 trials), "Biological" (4 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Docetaxel" (7 trials), "Carboplatin" (5 trials), "Gemcitabine" (5 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Cancer Medical Center Inc" are 73 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Pacific Cancer Medical Center Inc". undefined are not yet recruiting, 13 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Pacific Cancer Medical Center Inc, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Cancer Medical Center Inc, 10 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".